APA (7th ed.) Citation

Y, T., T, M., T, A., K, A., N, I., E, S., . . . T, T. (2022). Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1). Modern rheumatology, 32(2), 263. https://doi.org/10.1093/mr/roab030

Chicago Style (17th ed.) Citation

Y, Tanaka, et al. "Efficacy and Safety of Filgotinib in Combination with Methotrexate in Japanese Patients with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate: Subpopulation Analyses of 24-week Data of a Global Phase 3 Study (FINCH 1)." Modern Rheumatology 32, no. 2 (2022): 263. https://doi.org/10.1093/mr/roab030.

MLA (9th ed.) Citation

Y, Tanaka, et al. "Efficacy and Safety of Filgotinib in Combination with Methotrexate in Japanese Patients with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate: Subpopulation Analyses of 24-week Data of a Global Phase 3 Study (FINCH 1)." Modern Rheumatology, vol. 32, no. 2, 2022, p. 263, https://doi.org/10.1093/mr/roab030.